NGQ-27529-63884
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 175 / PA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-29
- 2021-01-03
-
2021-01-10
Dose 2 — Pfizer-BioNTech
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-16
- 2021-01-19
- 2021-01-24
- 2021-02-02
- 2021-02-07
- 2021-02-15
- 2021-02-21
- 2021-04-11
- 2021-07-11
-
2022-01-10
Survey response — 12 months, dose 2MedDRA: Cough, Headache, Pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Runny nose, congestion, cough, headache, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 10 — 12 months, dose 2
Symptoms: Runny nose, congestion, cough, headache, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release